Comparison of NT Vs Body Weight Supported TT Along With CT on Lower Extremity in Chronic Stroke Patients

To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Stroke

Age range

35 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

• General Hospital. • Chaudhary Muhammad Akram Teaching and Research Hospital, University of Lahore Teaching Hospital, Shadman Medical Center, Services Hospital, Bahria International Hospital

Lahore, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Application of M-Cog test for checking patients cognition.
Chronic ischemic stroke patients.
Both Male and Female Patients.
Patients of 35 or above years of age.

Exclusion criteria

Patients with history of recurrent stroke.
Patients with lower limb fractures or dislocations.
Patients with Peripheral vascular disease
Patients with skin discoloration or skin ulcers.

Treatment and study plan

Neurodevelopmental Treatment

Diagnostic Test

Using Neurodevelopmental Treatment Method

Body weight supported treadmill training along with conventional therapy

Diagnostic Test

Using Body weight supported treadmill training along with conventional therapy Method

Primary outcomes

For lower extremity among chronic stroke patients

Time frame: 6 Months

comparison of neurodevelopmental treatment vs body weight supported treadmill training along with conventional therapy on lower extremity among chronic stroke patients

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Comparison of Neurodevelopmental Treatment Vs Body Weight Supported Treadmill Training Along With Conventional Therapy on Lower Extremity Among Chronic Stroke Patients

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: May 17, 2022
Registry last updated: Aug 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed